Category Archives: BioUtah News

BioUtah Remembers Senator Orrin Hatch

By admin | Published April 28, 2022

Senator Orrin Hatch, who served 42 years in the Senate and is the longest serving Senator in Utah’s history, died at 88 last Saturday. He is remembered fondly by Utah’s life sciences industry as a stalwart champion for medical innovation and improving the lives of patients. Reflecting on the Senator’s life and legacy, Kelvyn Cullimore, […]

| Leave a comment

IDbyDNA Improves Analytical Performance and User Experience of Its Explify Platform and Respiratory and Urinary Pathogen ID/AMR Panels

By Natalie Themm | Published April 28, 2022

IDbyDNA develops Precision Metagenomic solutions with faster, comprehensive pathogen identification, quantification, and profiling powered by AI-driven genomic analysis and next-generation sequencing.

| Tagged IDbyDNA | Leave a comment

Biotech Perfect Day opens Location in BioHive Hub

By Natalie Themm | Published April 20, 2022

The Gateway, a growing campus for life sciences companies, will expand and diversify the footprint of Perfect Day’s technology capabilities and teams

| Tagged Perfect Day Inc, the gateway | Leave a comment

Thermo Fisher Scientific Expands in Utah with New Bioprocessing Manufacturing Site in Ogden

By Natalie Themm | Published April 20, 2022

Company now employs more than 2,000 people state-wide across three locations

| Tagged Thermo Fisher Scientific | Leave a comment

Merit Medical Receives FDA Clearance for SCOUT Bx™ Delivery System

By Natalie Themm | Published April 19, 2022

New technology is designed to allow physicians to place SCOUT® reflector at time of biopsy for breast localization under stereotactic and MRI guidance

| Tagged merit medical | Leave a comment

Merit Medical Receives FDA “Breakthrough Device Designation” for Embosphere® Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis

By Natalie Themm | Published April 19, 2022

SOUTH JORDAN, Utah, March 07, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), announced today that it has received “breakthrough device designation” from the U.S. Food & Drug Administration (FDA) for Embosphere® Microspheres for the Genicular Artery Embolization (GAE) indication. GAE is a procedure intended to reduce pain and disability caused by knee osteoarthritis by […]

| Tagged merit medical | Leave a comment

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis C Viral Load Test

By Natalie Themm | Published April 19, 2022

Co-Diagnostics announced that CoSara Diagnostics has received clearance by the CDSCO in India to manufacture and sell its SARAQ™ Hepatitis C Viral Load Kit as an in vitro diagnostic.

| Tagged co-diagnostics, co-dx | Leave a comment